Vaxcyte (PCVX) EPS (Basic) (2019 - 2026)

Vaxcyte (PCVX) posted quarterly EPS (Basic) of -$2.31 for Q1 2026, down 108.1% year-over-year from $28.57 in Q1 2025, and up 16.7% quarter-over-quarter from -$2.78 in Q4 2025.

Vaxcyte (PCVX) EPS (Basic) (2019 - 2026) Analysis & Trends

Vaxcyte (PCVX) has reported EPS (Basic) for 8 consecutive years, with -$2.31 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) fell 108.1% year-over-year to -$2.31; the TTM figure through Mar 2026 stood at -$9.67 (down 153.35% YoY), while the FY2025 annual figure was -$10.65, down 43.45% from the prior year.
  • EPS (Basic) advanced to -$2.31 in Q1 2026 per PCVX's latest filing, from -$2.78 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.91 in Q3 2023 and bottomed at -$6.42 in Q4 2023.
  • Historically, EPS (Basic) has averaged -$1.68 across 5 years, with a median of -$1.11 in 2025.
  • Annual changes were most pronounced in 2023 — EPS (Basic) soared 197.55% — and 2024, when it slumped 482.02%.
  • Vaxcyte's EPS (Basic) stood at -$1.2 in 2022, then sank by 433.64% to -$6.42 in 2023, then soared by 85.02% to -$0.96 in 2024, then tumbled by 189.01% to -$2.78 in 2025, then grew by 16.7% to -$2.31 in 2026.
  • Business Quant data shows PCVX's EPS (Basic) at -$2.31 in Q1 2026, -$2.78 in Q4 2025, and -$2.43 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Vaxcyte 8.41 Bn 8.41 Bn - -3.31

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.31
Mar 31, 2026 -2.31
Dec 31, 2025 -2.78
Sep 30, 2025 -2.43
Jun 30, 2025 -2.32
Mar 31, 2025 -1.11
Dec 31, 2024 -0.96
Sep 30, 2024 -0.93
Jun 30, 2024 -1.14
Mar 31, 2024 -4.08
Dec 31, 2023 -6.42
Sep 30, 2023 0.91
Jun 30, 2023 -0.70
Mar 31, 2023 -0.70
Dec 31, 2022 -1.20
Sep 30, 2022 -0.93
Jun 30, 2022 -0.80
Mar 31, 2022 -0.68
Dec 31, 2021 -0.55
Sep 30, 2021 -0.51